Search Results - "Kieran, Mark W."

Refine Results
  1. 1
  2. 2
  3. 3

    Role of Collagen Matrix in Tumor Angiogenesis and Glioblastoma Multiforme Progression by Mammoto, Tadanori, Jiang, Amanda, Jiang, Elisabeth, Panigrahy, Dipak, Kieran, Mark W, Mammoto, Akiko

    Published in The American journal of pathology (01-10-2013)
    “…Glioblastoma is a highly vascularized brain tumor, and antiangiogenic therapy improves its progression-free survival. However, current antiangiogenic therapy…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Identification of fibroblast heterogeneity in the tumor microenvironment by Sugimoto, Hikaru, Mundel, Thomas M, Kieran, Mark W., Kalluri, Raghu

    Published in Cancer biology & therapy (01-12-2006)
    “…Tumors are unorganized organs that contain many different cell types. In the recent years, many studies have reported that primary tumors contain…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome by GORDON, Leslie B, MASSARO, Joe, D'AGOSTINO, Ralph B, CAMPBELL, Susan E, BRAZIER, Joan, BROWN, W. Ted, KLEINMAN, Monica E, KIERAN, Mark W

    Published in Circulation (New York, N.Y.) (01-07-2014)
    “…Hutchinson-Gilford progeria syndrome is an ultrarare segmental premature aging disease resulting in early death from heart attack or stroke. There is no…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Adjunct Targeted Biologic Inhibition Agents to Treat Aggressive Multivessel Intraluminal Pediatric Pulmonary Vein Stenosis by Callahan, Ryan, Kieran, Mark W., Baird, Christopher W., Colan, Steven D., Gauvreau, Kimberlee, Ireland, Christina M., Marshall, Audrey C., Sena, Laureen M., Vargas, Sara O., Jenkins, Kathy J.

    Published in The Journal of pediatrics (01-07-2018)
    “…To evaluate the use of imatinib mesylate with or without bevacizumab targeting neoproliferative myofibroblast-like cells with tyrosine kinase receptor…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Platelets actively sequester angiogenesis regulators by Lakka Klement, Giannoula, Yip, Tai-Tung, Cassiola, Flavia, Kikuchi, Lena, Cervi, David, Podust, Vladimir, Italiano, Joseph E., Wheatley, Erin, Abou-Slaybi, Abdo, Bender, Elise, Almog, Nava, Kieran, Mark W., Folkman, Judah

    Published in Blood (19-03-2009)
    “…Clinical trials with antiangiogenic agents have not been able to validate plasma or serum levels of angiogenesis regulators as reliable markers of cancer…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    The Integration of Biology Into the Treatment of Diffuse Intrinsic Pontine Glioma: A Review of the North American Clinical Trial Perspective by Clymer, Jessica, Kieran, Mark W

    Published in Frontiers in oncology (18-05-2018)
    “…Dramatic advances in the molecular analysis of diffuse intrinsic pontine glioma have occurred over the last decade and resulted in the identification of…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic by Morales La Madrid, Andres, Hashizume, Rintaro, Kieran, Mark W

    Published in Frontiers in oncology (01-07-2015)
    “…In spite of major recent advances in diffuse intrinsic pontine glioma (DIPG) molecular characterization, this body of knowledge has not yet translated into…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma by Grill, Jacques, Puget, Stephanie, Andreiuolo, Felipe, Philippe, Cathy, MacConaill, Laura, Kieran, Mark W.

    Published in Pediatric blood & cancer (01-04-2012)
    “…Diffuse intrinsic pontine gliomas (DIPG) can not be cured with current treatment modalities. Targeted therapy in this disease would benefit from advanced…”
    Get full text
    Journal Article